Nisu SWASTİKA, Madhuri GAWANDE, Minal CHAUDHARY, Swati PATİL

Oral Candidal Carriage in Subgingival Sites and Its Subspecies Identification in Diabetic and Non-Diabetic Patients with Periodontitis

Anahtar Kelimeler:

-

Oral Candidal Carriage in Subgingival Sites and Its Subspecies Identification in Diabetic and Non-Diabetic Patients with Periodontitis

Candida is the most common fungal pathogen of oral cavity in humans. It exists as a commensal inhabitant of mucosal surfaces in most healthy individuals. Periodontitis is an inflammatory disease of the periodontium with multifactorial etiology. There is a positive relationship between periodontal inflammation and type 2 diabetes. Diabetes is a metabolic disease characterized by hyperglycemia due to defects in insulin production, insulin action, or both. Diabetes mellitus can impair the function of polymorphonuclear leukocytes which may predispose diabetic patients to greater risk of diseases including periodontal disease and oral candidal infections . The objective of this study is to evaluate the oral candidal carriage in the subgingival sites and also to evaluate the predominant candidal subtypes in non-diabetic individuals with periodontitis, diabetic individuals with periodontitis and healthy individuals without periodontitis. Clinical article (J Int Dent Med Res 2013; 6: (2), pp. 69-73)

Keywords:

Candidal carriage, diabetes periodontitis.,

PDF

___

Rindum JL, Stenderup A, Holmstrup P: Identification of Candida albicans types related to healthy and pathological oral mucosa. J Oral Pathol Med 1994, 23:406-412.
Janaina C.O. Sardi, Cristiane Duque, Flavia S. Mariano: Candida species in periodontal disease: a brief review. Journal of oral science, 2010, 52, 177-185.
Fawad Javed, Lena Klingspor, Ulf Sundin:Periodontal conditions, oral Candida albicans and salivary proteins in type 2 diabetic subjects with emphasis on gender. BMC Oral Health, 2009, 9:12 .
Janet H. Southerland, George W. Taylor,Steven Offenbacher : Diabetes and Periodontal Infection: Making the Connection. Clinical Diabetes October 2005vol. 23 no. 4 171-178. Levent Kardeşler, Nurcan Buduneli, Başak Bıyıkoğlu : Gingival crevicular fluid PGE 2 , IL1ß, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease. Clinical Biochemistry, July 2008, vol 41, 863-868.
Samarnayake L.P., Hughes A., Weetman D.A. (1986): Growth and acid production of candida species in human saliva supplemented with glucose. Journal of Oral Pathology, 15, 2512
Critchley I.A. and DouglasL.J.(1987) :Role of glycosides as epithelial cell receptors for candida albicans. Journal of General Microbiology,133, 629-636.
Ruchel R., Boening B., Borg M.(1986) : Characterization of secretory proteinase of candida parapsilosis and evidence for the absence of enzyme during infection in vitro. Infection and Immunity, 53, 411-419.
Diamond R.D., Oppenheim F., Nakagawa Y.(1980): Properties of a product of candida albicans hyphae and pseudohyphae that inhibits contact between the fungi and human neutrophils in vitro. Journal of immunology, 125, 2797-2804.
Rivas and Rogers, T.J.(1983): Studies on the cellular nature of Candida albicans-induced suppression. Journal of Immunology, 130, 376-379.
Cuff C.F., Rogers C.M., Lamb B.J. (1986). Induction of suppressor cells in vitro by Candida albicans. Cellular Immunology, 100, 47-56.
Lombardi G., Vismara D., Piccolella E. (1985): A non-specific inhibitor produced by Candida albicans activated T cells impairs cell proliferation by inhibiting interleukin-1 production. Clinical and Experimental Immunology, 60,303-310.